What is ENOUGH?
Founded in 2015, ENOUGH—formerly known as 3F BIO—operates at the intersection of biotechnology and food science. The company specializes in the production of high-quality protein derived from fungi, utilizing a highly efficient fermentation process that significantly reduces the environmental footprint compared to conventional livestock farming. Based in Scotland, the firm has developed a unique platform that mimics the texture and nutritional profile of animal proteins, making it a highly sought-after ingredient for food manufacturers looking to diversify their plant-based portfolios.
The company's market position is defined by its focus on scalability and sustainability. By integrating its technology into existing food supply chains, ENOUGH provides a viable pathway for the industry to meet the rising global demand for protein while simultaneously achieving ambitious decarbonization targets. Their approach is not merely about creating a niche product but about establishing a new standard for industrial-scale protein manufacturing.
How much funding has ENOUGH raised?
ENOUGH has raised a total of $43.5M across 1 funding round:
Other Financing Round
$43.5M
Other Financing Round (2023): $43.5M with participation from CPT Capital, World Fund, and HAL Investments
Key Investors in ENOUGH
CPT Capital
CPT Capital is an investment firm focused on the future of food and materials, specifically in the alternative protein sector. They partner with visionary founders and companies that utilize cutting-edge technologies to replace animals in the supply chain.
World Fund
World Fund is a leading European venture capital fund that invests in entrepreneurs developing climate technology capable of reducing at least 100 million tons of CO2e emissions annually.
HAL Investments
HAL Investments is the Dutch investment subsidiary of HAL Holding N.V., focusing on acquiring significant shareholdings in various companies to enhance long-term shareholder value.
What's next for ENOUGH?
With the recent capital infusion, ENOUGH is well-positioned to scale its production capacity and expand its commercial reach across international markets. The strategic focus will likely center on optimizing manufacturing efficiency and deepening partnerships with major food producers who are eager to integrate sustainable protein sources into their product lines. As the company moves into this next phase of growth, the emphasis will remain on proving the long-term viability of its fungal-based protein at an industrial scale, thereby cementing its role as a cornerstone of the future food economy. The backing from specialized climate and food-tech investors provides not only the necessary liquidity but also the strategic guidance required to navigate the complexities of the global food system.
See full ENOUGH company page
